{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:13:44Z","timestamp":1756383224115},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Peritoneal dialysis (PD)-related peritonitis is a rare but serious complication and is associated with increased morbidity and mortality rates. It is most commonly caused by <jats:italic>Staphylococcus aureus<\/jats:italic> or <jats:italic>Staphylococcus epidermidis<\/jats:italic>, but infection with <jats:italic>Listeria monocytogenes<\/jats:italic> may also occur. Recommendations for antibiotic treatment of a Listeria infection are currently based on a small number of case reports and suggest the administration of ampicillin. But unlike vancomycin or gentamicin, for ampicillin the route of application, the dosage, and the duration of treatment have not yet been established. We report a case in which PD-associated peritonitis due to Listeria infection was treated with ampicillin administered intravenously and intraperitoneally, separately and in combination.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 72-year-old man with chronic kidney disease stage 5 dialysis (CKDG5D) secondary to hypertension and diabetes was hospitalised in April 2020 because of PD-related peritonitis caused by a Listeria infection. In accordance with the results of resistance tests, the patient was treated with intravenous ampicillin at a dosage of 6\u2009g twice daily. After initial treatment the leukocyte count in the PD effluent had decreased substantially, but it was permanently reduced only with the addition of intraperitoneal ampicillin (4\u2009g daily). Efficient serum concentrations of ampicillin were determined for both routes of administration, intravenous and intraperitoneal.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This is the first case report demonstrating that PD-related peritonitis due to <jats:italic>Listeria monocytogenes<\/jats:italic> infection can be treated with intraperitoneal ampicillin and monitored by the determination of peripheral serum concentrations of ampicillin.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-02068-1","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T13:03:48Z","timestamp":1600434228000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intraperitoneal ampicillin treatment for peritoneal dialysis- related peritonitis with Listeria monocytogenes \u2013 a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Kristina","family":"Boss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Wiegard-Szramek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Dziobaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"issue":"2","key":"2068_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","volume":"64","author":"Y Cho","year":"2014","unstructured":"Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278\u201389.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2068_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","volume":"36","author":"PK Li","year":"2016","unstructured":"Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481\u2013508.","journal-title":"Perit Dial Int"},{"issue":"10","key":"2068_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3109\/00365521.2012.704935","volume":"47","author":"GD Liatsos","year":"2012","unstructured":"Liatsos GD, Thanellas S, Pirounaki M, Ketikoglou I, Moulakakis A. Listeria monocytogenes peritonitis: presentation, clinical features, treatment, and outcome. Scand J Gastroenterol. 2012;47(10):1129\u201340.","journal-title":"Scand J Gastroenterol"},{"key":"2068_CR4","volume-title":"Deutsche Gesellschaft f\u00fcr Neurologie, Hrsg. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"H-W Pfister","year":"2015","unstructured":"Pfister H-W, et al. S2k-Leitlinie Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter. In: Deutsche Gesellschaft f\u00fcr Neurologie, Hrsg. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie; 2015. Online: www.dgn.org\/leitlinien (Accessed 15.08.2020)."},{"key":"2068_CR5","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2020","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, vol. Version 10.0; 2020. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_10.0_Breakpoint_Tables.pdf (Accessed 13.08.2020)."},{"issue":"2","key":"2068_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3747\/pdi.2016.00205","volume":"37","author":"W Beckerleg","year":"2017","unstructured":"Beckerleg W, Keskar V, Karpinski J. Peritonitis as the First Presentation of Disseminated Listeriosis in a Patient on Peritoneal Dialysis-a Case Report. Perit Dial Int. 2017;37(2):239\u201340.","journal-title":"Perit Dial Int"},{"key":"2068_CR7","doi-asserted-by":"publisher","first-page":"bcr2017220088","DOI":"10.1136\/bcr-2017-220088","volume":"2018","author":"HB Poulsen","year":"2018","unstructured":"Poulsen HB, \u00c1 Steig T, Bj\u00f6rkman JT, Gaini S. Peritonitis with Listeria monocytogenes in a patient on automated peritoneal dialysis. BMJ Case Rep. 2018;2018:bcr2017220088.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2068_CR8","first-page":"129","volume":"18","author":"A Moscovici","year":"2016","unstructured":"Moscovici A, Kogan M, Kliers I, Kukuy O, Segal G. Listeria peritonitis in a patient treated with peritoneal Dialysis. Isr Med Assoc J. 2016;18(2):129\u201330.","journal-title":"Isr Med Assoc J"},{"issue":"8","key":"2068_CR9","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2215\/CJN.12211211","volume":"7","author":"JM Varghese","year":"2012","unstructured":"Varghese JM, Roberts JA, Wallis SC, Boots RJ, Healy H, Fassett RG, Lipman J, Ranganathan D. Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study). Clin J Am Soc Nephrol. 2012;7(8):1249\u201356.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2068_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2215\/CJN.05690611","volume":"7","author":"JM Lorenzen","year":"2012","unstructured":"Lorenzen JM, Broll M, Kaever V, Burhenne H, Hafer C, Clajus C, Knitsch W, Burkhardt O, Kielstein JT. Pharmacokinetics of ampicillin\/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. Clin J Am Soc Nephrol. 2012;7(3):385\u201390.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2068_CR11","first-page":"107","volume":"19","author":"M de Paepe","year":"1983","unstructured":"de Paepe M, Lameire N, Belpaire F, Bogaert M. Peritoneal pharmacokinetics of gentamicin in man. Clin Nephrol. 1983;19(3):107\u20139.","journal-title":"Clin Nephrol"},{"key":"2068_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/089686089001000307","volume":"10","author":"BG Blackwell","year":"1990","unstructured":"Blackwell BG, Leggett JE, Johnson CA, Zimmerman SW, Craig WA. Ampicillin and sulbactam pharmacokinetics and pharmacodynamics in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int. 1990;10:221\u20136.","journal-title":"Perit Dial Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:14:21Z","timestamp":1631920461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02068-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patient gave written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written informed consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}